课题基金 / 基金详情

21 HYDROXYLASE DEFICIENCY CONGENITAL ADRENAL HYPERPLASIA

21 HYDROXYLASE DEFICIENCY CONGENITAL ADRENAL HYPERPLASIA
21 羟化酶缺乏症 先天性肾上腺增生
批准号:
6246628
负责人:
SELMA FELDMAN WITCHEL
金额:
$1.91万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-12-01 至 1997-11-30

项目摘要

项目成果

SELMA FELDMAN WITCHEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this study is to utilize the congenital adrenal hyperplasia, inborn errors of steroidogenesis, to improve knowledge regarding the pathophysiology of disorders associated with hyperandrogenism. A secondary goal is better understanding of how the hypothalamic-pituitary- adrenal axis functions. We are correlating clinical features, hormonal (biochemical) phenotype, and genotype. The information obtained from this study will help develop optimal treatment for children with congenital adrenal hyperplasia and differentiate which children with mild hyperandrogenism require treatment with glucocorticoid and/or mineralocorticoid medications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF ABNORMAL SEXUAL DIFFERENTIATION AND DEVELOPMENT:SERUM INHIBIN B & FSH
STEROIDOGENESIS IN HYPERANDROGENISM
EVALUATION & TREATMENT OF ABNORMALITIES OF GONADAL OR PUBERTAL DEVELOPMENT
MOLECULAR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA: PHENOTYPE/GENOTYPE
海外基金